Pseudomonas beta ferritin
| Internal ID | 4a408f44-9754-42fb-bed2-bfae77019af2 |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Oligopeptides |
| IUPAC Name | 4-[[1-[2-[[2-[[5-amino-2-[(2-amino-4-methylsulfanylbutanoyl)amino]-5-oxopentanoyl]amino]acetyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-5-[[1-[[1-[[3-carboxy-1-[[1-(4-hydroxyphenyl)-3-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-oxopentanoic acid |
| SMILES (Canonical) | CCC(C)C(C(=O)NC(CC(=O)O)C(=O)NC(CC1=CC=C(C=C1)O)C=O)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)O)NC(=O)C2CCCN2C(=O)C(CC3=CN=CN3)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CCSC)N |
| SMILES (Isomeric) | CCC(C)C(C(=O)NC(CC(=O)O)C(=O)NC(CC1=CC=C(C=C1)O)C=O)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)O)NC(=O)C2CCCN2C(=O)C(CC3=CN=CN3)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CCSC)N |
| InChI | InChI=1S/C52H77N13O16S/c1-6-28(4)44(51(80)62-36(22-42(72)73)48(77)58-31(25-66)20-29-9-11-32(67)12-10-29)64-50(79)43(27(2)3)63-47(76)35(14-16-41(70)71)61-49(78)38-8-7-18-65(38)52(81)37(21-30-23-55-26-57-30)59-40(69)24-56-46(75)34(13-15-39(54)68)60-45(74)33(53)17-19-82-5/h9-12,23,25-28,31,33-38,43-44,67H,6-8,13-22,24,53H2,1-5H3,(H2,54,68)(H,55,57)(H,56,75)(H,58,77)(H,59,69)(H,60,74)(H,61,78)(H,62,80)(H,63,76)(H,64,79)(H,70,71)(H,72,73) |
| InChI Key | SISUIWQKEBULAB-UHFFFAOYSA-N |
| Popularity | 1 reference in papers |
| Molecular Formula | C52H77N13O16S |
| Molecular Weight | 1172.30 g/mol |
| Exact Mass | 1171.53319459 g/mol |
| Topological Polar Surface Area (TPSA) | 488.00 Ų |
| XlogP | -4.10 |
| Atomic LogP (AlogP) | -3.01 |
| H-Bond Acceptor | 17 |
| H-Bond Donor | 14 |
| Rotatable Bonds | 36 |
| 4-((1-(2-((2-((5-amino-2-((2-amino-4-methylsulfanylbutanoyl)amino)-5-oxopentanoyl)amino)acetyl)amino)-3-(1H-imidazol-5-yl)propanoyl)pyrrolidine-2-carbonyl)amino)-5-((1-((1-((3-carboxy-1-((1-(4-hydroxyphenyl)-3-oxopropan-2-yl)amino)-1-oxopropan-2-yl)amino)-3-methyl-1-oxopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)amino)-5-oxopentanoic acid |
| 4-[[1-[2-[[2-[[5-amino-2-[(2-amino-4-methylsulfanylbutanoyl)amino]-5-oxopentanoyl]amino]acetyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-5-[[1-[[1-[[3-carboxy-1-[[1-(4-hydroxyphenyl)-3-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-oxopentanoic acid |
| RefChem:176948 |
| CHEBI:225965 |
| 4-[[1-[2-[[2-[[5-amino-2-[(2-amino-4-methylsulanylbutanoyl)amino]-5-oxopentanoyl]amino]acetyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-5-[[1-[[1-[[3-carboxy-1-[[1-(4-hydroxyphenyl)-3-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-oxopentanoic acid |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.8054 | 80.54% |
| Caco-2 | - | 0.8673 | 86.73% |
| Blood Brain Barrier | - | 0.9250 | 92.50% |
| Human oral bioavailability | - | 0.7286 | 72.86% |
| Subcellular localzation | Lysosomes | 0.5333 | 53.33% |
| OATP2B1 inhibitior | - | 0.8577 | 85.77% |
| OATP1B1 inhibitior | + | 0.8000 | 80.00% |
| OATP1B3 inhibitior | + | 0.9280 | 92.80% |
| MATE1 inhibitior | - | 0.9009 | 90.09% |
| OCT2 inhibitior | - | 0.8500 | 85.00% |
| BSEP inhibitior | + | 0.9377 | 93.77% |
| P-glycoprotein inhibitior | + | 0.7428 | 74.28% |
| P-glycoprotein substrate | + | 0.8634 | 86.34% |
| CYP3A4 substrate | + | 0.7383 | 73.83% |
| CYP2C9 substrate | - | 0.6156 | 61.56% |
| CYP2D6 substrate | - | 0.8447 | 84.47% |
| CYP3A4 inhibition | - | 0.9030 | 90.30% |
| CYP2C9 inhibition | - | 0.8554 | 85.54% |
| CYP2C19 inhibition | - | 0.8316 | 83.16% |
| CYP2D6 inhibition | - | 0.9121 | 91.21% |
| CYP1A2 inhibition | - | 0.9086 | 90.86% |
| CYP2C8 inhibition | + | 0.8087 | 80.87% |
| CYP inhibitory promiscuity | - | 0.9424 | 94.24% |
| UGT catelyzed | - | 0.5000 | 50.00% |
| Carcinogenicity (binary) | - | 0.8000 | 80.00% |
| Carcinogenicity (trinary) | Non-required | 0.6344 | 63.44% |
| Eye corrosion | - | 0.9882 | 98.82% |
| Eye irritation | - | 0.8971 | 89.71% |
| Skin irritation | - | 0.7805 | 78.05% |
| Skin corrosion | - | 0.9237 | 92.37% |
| Ames mutagenesis | - | 0.8100 | 81.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7409 | 74.09% |
| Micronuclear | + | 0.8000 | 80.00% |
| Hepatotoxicity | - | 0.5073 | 50.73% |
| skin sensitisation | - | 0.8764 | 87.64% |
| Respiratory toxicity | + | 0.8778 | 87.78% |
| Reproductive toxicity | + | 0.9667 | 96.67% |
| Mitochondrial toxicity | + | 0.8750 | 87.50% |
| Nephrotoxicity | - | 0.9066 | 90.66% |
| Acute Oral Toxicity (c) | III | 0.5255 | 52.55% |
| Estrogen receptor binding | + | 0.6753 | 67.53% |
| Androgen receptor binding | + | 0.6632 | 66.32% |
| Thyroid receptor binding | + | 0.6573 | 65.73% |
| Glucocorticoid receptor binding | + | 0.6868 | 68.68% |
| Aromatase binding | + | 0.7066 | 70.66% |
| PPAR gamma | + | 0.7082 | 70.82% |
| Honey bee toxicity | - | 0.6913 | 69.13% |
| Biodegradation | - | 0.8250 | 82.50% |
| Crustacea aquatic toxicity | - | 0.5600 | 56.00% |
| Fish aquatic toxicity | + | 0.8024 | 80.24% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.96% | 98.95% |
| CHEMBL4801 | P29466 | Caspase-1 | 99.56% | 96.85% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.21% | 96.09% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 99.14% | 97.23% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 98.99% | 100.00% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 98.36% | 94.45% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 98.25% | 98.33% |
| CHEMBL236 | P41143 | Delta opioid receptor | 98.12% | 99.35% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 97.81% | 97.64% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 97.60% | 90.20% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 96.97% | 89.63% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 96.12% | 93.10% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 96.02% | 98.94% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 96.01% | 98.24% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 95.71% | 82.69% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 94.73% | 100.00% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 94.61% | 93.00% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 94.52% | 97.09% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 94.37% | 90.71% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 93.79% | 90.08% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 93.28% | 93.56% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 93.17% | 88.42% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 93.09% | 94.00% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 93.00% | 99.17% |
| CHEMBL249 | P25103 | Neurokinin 1 receptor | 92.77% | 99.17% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 92.52% | 96.67% |
| CHEMBL2535 | P11166 | Glucose transporter | 92.10% | 98.75% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 91.75% | 96.03% |
| CHEMBL227 | P30556 | Type-1 angiotensin II receptor | 91.62% | 99.53% |
| CHEMBL4208 | P20618 | Proteasome component C5 | 91.54% | 90.00% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 91.43% | 96.67% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 91.37% | 95.38% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 90.56% | 91.11% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 90.33% | 95.56% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 89.93% | 95.89% |
| CHEMBL2803 | P43403 | Tyrosine-protein kinase ZAP-70 | 89.69% | 82.50% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 88.80% | 95.00% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 88.10% | 91.19% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 87.61% | 96.90% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 87.49% | 82.38% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 86.72% | 95.89% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 86.29% | 88.56% |
| CHEMBL2334 | P42574 | Caspase-3 | 86.18% | 98.25% |
| CHEMBL1907589 | P17787 | Neuronal acetylcholine receptor; alpha4/beta2 | 86.09% | 94.55% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 85.68% | 100.00% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 84.73% | 93.33% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 84.69% | 96.00% |
| CHEMBL2001 | Q9H244 | Purinergic receptor P2Y12 | 84.66% | 96.00% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 84.34% | 96.28% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 84.32% | 95.52% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 84.15% | 85.00% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 83.26% | 94.66% |
| CHEMBL2095164 | P49354 | Geranylgeranyl transferase type I | 81.85% | 92.80% |
| CHEMBL4393 | P39900 | Matrix metalloproteinase 12 | 81.75% | 92.22% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 81.62% | 97.21% |
| CHEMBL5203 | P33316 | dUTP pyrophosphatase | 81.60% | 99.18% |
| CHEMBL3776 | Q14790 | Caspase-8 | 81.44% | 97.06% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 81.19% | 90.17% |
| CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 81.13% | 100.00% |
| CHEMBL3784 | Q09472 | Histone acetyltransferase p300 | 80.94% | 93.33% |
| CHEMBL1293287 | P14735 | Insulin-degrading enzyme | 80.85% | 88.10% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 80.66% | 97.43% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 80.58% | 89.50% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 80.55% | 95.17% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139587877 |
| LOTUS | LTS0022870 |
| wikiData | Q105254013 |